GovChime
Notice ID: b69837c6d9fa4e25aead542e58e922cfSolicitation

Using Transgenic Mouse to Generate Human Antibodies

Archived on June 15, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
5:00 PM UTC−04:00
Posted
May 17, 2022
Notice type
Solicitation
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION

Notice details

Office
CDC OFFICE OF ACQUISITION SERVICES
Place of performance
Atlanta, GA, 30329
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75D301-22-Q-74781
Notice ID
b69837c6d9fa4e25aead542e58e922cf

Description

CDC seeks to test a transgenic mouse model that is engineered with human immunoglobulin gene segments to produce humanized antibodies, with the goal of determining if the antibodies generated from that mouse model can better recapitulate the antibody repertoire from humans. Overall objective is to provide the Influenza Division with transgenic mice that express human antibody repertoire, which would be useful for assessing the efficacy of CVVs and developing antibodies.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75D301-22-Q-74781
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. SolicitationCurrentMay 17, 2022

    Using Transgenic Mouse to Generate Human Antibodies

    Notice b69837c6d9fa4e25aead542e58e922cf on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75D301-22-Q-74781

Archive Date

Jun 15, 2022

Office Address

ATLANTA, GA, 30333